Abstract The lack of targeted therapies for triple-negative breast cancer (TNBC) contributes to their high mortality rates and high risk of relapse compared to other subtypes of breast cancer. Most TNBCs (75%) have downregulated the expression of CREB3L1 (cAMP-responsive element binding protein 3 like 1). a transcription factor and metastasis suppressor that represses genes that promo... https://parisnaturalfoodes.shop/product-category/org-plant-calcium/